Karachi, Citi Pharma Limited informed Pakistan Stock Exchange that the agreement has been signed between the Company and Deputy Governor Namangan Region, Uzbekistan to establish a wholly subsidiary of the Company in Uzbekistan. This venture will enable the Company to produce Syrups, Liquids, Psychotropic Products and general Section etc.
Citi Pharma Limited incorporated as a private limited company in Pakistan on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The factory is located at 3km Head Balloki road, Kasur. It has a land of 47 acres and has more than 800,000 Sq. Feet covered area.
The total numbers of shares are 207,692,000. The Earnings per share is 32.36 in 2020 which was 6.18 in 2019. The Profit after Taxation is 145,635,000 in 2020 which was 27,804,000 in 2019.